Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

SummaryNewsCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsSector newsTweets 

PRESSURE BIOSCIENC : Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/14/2008 | 10:15pm CET

SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its third quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Monday, November 17, 2008

Time: 4:30 p.m. Eastern Standard Time (EST)

To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com

    To attend this teleconference via telephone:
    Dial-in: (800) 344-6491
    Participant code: 3034253

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends, and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

    Investor Contacts:
    Richard T. Schumacher, President & CEO
    Edward H. Myles, Senior Vice President of Finance & CFO
    Pressure BioSciences, Inc.
    (T) 508-230-1828

SOURCE Pressure BioSciences, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PRESSURE BIOSCIENCES, INC.
01/10 PRESSURE BIOSCIENCES INC : Pressure BioSciences, Inc. to Present at the 2017 Bio..
01/10 PRESSURE BIOSCIENCES, INC. : to Present at the 2017 Biotech Showcase
01/03 PRESSURE BIOSCIENCES : NetworkNewsBreaks – Pressure BioSciences, Inc. (PBI..
2016 PRESSURE BIOSCIENCES, INC. (OTCMKTS : PBIO) Files An 8-K Submission of Matters t..
2016 PRESSURE BIOSCIENCES INC : Submission of Matters to a Vote of Security Holders (..
2016 PRESSURE BIOSCIENCES, INC. : Well Positioned to Play Important Role in US's $1.8..
2016 PRESSURE BIOSCIENCES : PBIO) Achieves Record Revenue on Road to Profitability --..
2016 PRESSURE BIOSCIENCES INC : WallStreet Research Announces Availability of Updated..
2016 PRESSURE BIOSCIENCES, INC. : Reports Third Quarter 2016 Financial Results and Pr..
2016 PRESSURE BIOSCIENCES : Management's Discussion and Analysis of Financial Conditi..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
01/17DJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
01/17DJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
01/17DJWHAT'S NEWS : Business & Finance -- WSJ
01/16 ESSILOR INTL : Luxottica's merger helps Del Vecchio manage family risks
01/16DJLUXOTTICA : Another Big Splash by Italy's Eyewear King
More sector news : Medical Equipment, Supplies & Distribution - NEC